Recursion Pharmaceuticals Inc (RXRX) — Net Asset Quality Index
Recursion Pharmaceuticals Inc (RXRX) has a Net Asset Quality Index of 76.5% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.34 Billion minus total liabilities of $314.75 Million yields net assets of $1.02 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See defensive interval ratio of Recursion Pharmaceuticals Inc to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Recursion Pharmaceuticals Inc Net Asset Quality Index Over Time (2019–2025)
This chart shows how Recursion Pharmaceuticals Inc's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the index stands at 76.5%, representing net assets of $1.02 Billion against total assets of $1.34 Billion USD. Explore RXRX cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Recursion Pharmaceuticals Inc (2019–2025)
The table below presents the year-by-year Net Asset Quality Index for Recursion Pharmaceuticals Inc from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Recursion Pharmaceuticals Inc (RXRX) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 76.7% | $1.13 Billion | $1.47 Billion | $343.26 Million | ▲ +5.3 pp |
| 2024 | 71.4% | $1.03 Billion | $1.45 Billion | $413.82 Million | ▲ +0.5 pp |
| 2023 | 70.9% | $463.44 Million | $653.70 Million | $190.26 Million | ▲ +1.6 pp |
| 2022 | 69.3% | $485.81 Million | $701.29 Million | $215.48 Million | ▼ -19.7 pp |
| 2021 | 89.0% | $542.94 Million | $610.35 Million | $67.41 Million | ▲ +158.0 pp |
| 2020 | -69.1% | $-206.29 Million | $298.58 Million | $504.87 Million | ▲ +53.4 pp |
| 2019 | -122.5% | $-124.27 Million | $101.43 Million | $225.70 Million | — |